Drug Shortage Report for PMS-RISPERIDONE
| Report ID | 208577 |
| Drug Identification Number | 02279266 |
| Brand name | PMS-RISPERIDONE |
| Common or Proper name | RISPERIDONE |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RISPERIDONE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL ORAL |
| Packaging size | 30ml |
| ATC code | N05AX |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-10-27 |
| Estimated end date | 2024-03-11 |
| Actual end date | 2024-03-15 |
| Shortage status | Resolved |
| Updated date | 2024-03-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2024-03-16 | English | Compare |
| v10 | 2024-03-15 | French | Compare |
| v9 | 2024-03-15 | English | Compare |
| v8 | 2024-02-16 | French | Compare |
| v7 | 2024-02-16 | English | Compare |
| v6 | 2024-02-09 | French | Compare |
| v5 | 2024-02-09 | English | Compare |
| v4 | 2023-12-27 | French | Compare |
| v3 | 2023-12-27 | English | Compare |
| v2 | 2023-10-30 | French | Compare |
| v1 | 2023-10-30 | English | Compare |
Showing 1 to 11 of 11